CordenPharma Chenôve increases lipid manufacturing capacity to support mRNA vaccine strategy CordenPharma, a full-service CDMO, has kicked off a major investment project to increase lipid manufacturing capacity at its Chenôve facility, near Dijon, France. This strategic decision was a result of the greatly increased demand to supply millions of…..
